Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-25 @ 2:27 PM
Study NCT ID:
NCT05126966
Status:
WITHDRAWN
Last Update Posted:
2024-01-18
First Post:
2021-10-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-29
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-28
First Submit QC Date:
None
Study First Post Date:
2021-11-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-17
Last Update Post Date:
2024-01-18
Last Update Post Date Type:
ACTUAL